The ins and outs of venous access: Part II

Nutrition in Clinical Practice

Volumn 17, Issue 3, 2002, Pages 142-155

  Vanek, Vincent W ^a  

^a ST ELIZABETH HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012037966     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426502017003142     Document Type: Review

References (115)

1. Ryder MA. Peripheral access options. Surg Oncol Clin N Am 4:395-427, 1995.
2. Sketch MH, Cale M, Mohiuddin SM. Use of percutaneously inserted venous catheters in coronary care units. Chest 62:684-689, 1972.
3. Hoshal VL Jr. Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg 110:644-646, 1975.
4. Cunningham RS, Ravikumar TS. A review of peripherally inserted central venous catheters in oncology patients. Surg Oncol Clin N Am 5:429-441, 1995.
5. Hadaway LC. Comparison of vascular access devices. Semin Oncol Nurs 11:154-166, 1995.
6. Thompson SE. Insertion of peripherally inserted central catheters for the administration of total parenteral nutrition (TPN). Nutr Clin Pract14:191-193;1999.
7. Goodwin ML. The Seldinger method for PICC insertion. J Intraven Nurs 12:238-243, 1989.
8. Goodwin ML, Carlson I. The peripherally inserted central catheter: a retrospective look at three years of insertions. J Intraven Nurs 16:92-103, 1993.
9. Cardella JF, Fox PS, Lawler JB. Interventional radiologic placement of peripherally inserted central catheters. J Vase Interv Radiol 4:653-660, 1993.
10. Asch MR. Venous access: options, approaches, and issues. Can Assoc Radiol J 52:153-164, 2001.
11. Cardella JF, Cardella K, Bacci N, et al. Cumulative experience with 1, 273 peripherally inserted central catheters at a single institution. J Vase Interv Radiol 7:5-13, 1996.
12. Ng PK, Ault MJ, Ellrodt AG, et al. Peripherally inserted central catheters in general medicine. Mayo Clin Proc 72:225-233, 1997.
13. Cardella JF, Fox PS, Lawler JB. Interventional radiologic placement of peripherally inserted central catheters. J Vase Interv Radiol 4:653-660, 1993.
14. Ng PK, Ault MJ, Maldonado LS. Peripherally inserted central catheters in the intensive care unit. J Intensive Care Med 11:49-54, 1996.
15. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: An overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 24:262-277, 1996.
16. Bottino J, McCredie KB, Groschel DH, et al. Long-term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseases. Cancer 43:1937-1943, 1979.
17. Lam S, Scannell R, Roessler D, et al. Peripherally inserted central catheters in an acute-care hospital. Arch Intern Med 154:1833-1837, 1994.
18. Lum PS, Soski M. Management of malpositioned central venous catheters. J Intraven Nurs 12:356-365, 1989.
19. LaFortune S. The use of confirming x-rays to verify tip position for peripherally inserted catheters. J Intraven Nurs 16:246-250, 1993.
20. Loughran SC, Borzatta M. Peripherally inserted central catheters: A report of 2506 catheter days. JPEN 19:133-136, 1995.
21. Alhimyary A, Fernandez C, Picard M, et al. Safety and efficacy of TPN delivered via a peripherally inserted central venous catheter. Nutr Clin Pract 11:199-203, 1996.
22. Hinson EK, Blough LD. Skilled IV therapy clinicians' product evaluation of open-ended versus closed-ended valve PICC lines: A cost savings clinical report. J Intraven Nurs 19:198-210, 1996.
23. Vanek VW. The ins and outs of venous access: part I. Nutr Clin Pract 17:81-98, 2002.
24. Smith JR, Friedell ML, Cheatham ML, et al. Peripherally inserted central catheters revisited. Am J Surg 176:208-211, 1998.
25. Duerksen DR, Papineau N, Siemens J, et al. Peripherally inserted central catheters for parenteral nutrition: A comparison with centrally inserted catheters. JPEN 23:85-89, 1999.
26. Graham DR, Keldermans MM, Klemm LW, et al. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 91:95S-100S, 1991.
27. JPEN. Section III: Routes to deliver nutrition support in adults. JPEN 17:7SA-11SA, 1993.
28. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 136:602-606, 1973.
29. Hickman RO, Buckner CD, Clift RA, et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148:871-875, 1979.
30. Malviya VK, Deppe G, Gove N, et al. Vascular access in gynecologic cancer using the Groshong right atrial catheter. Gynecol Oncol 33:313-316, 1989.
31. Docktor BL, Sadler DJ, Gray RR, et al. Radiologic placement of tunneled central catheters: Rates of success and of immediate complications in a large series. AJR 173:457-460, 1999.
32. Mauro MA, Jaques PF. Radiologic placement of long-term central venous catheters: A review. J Vase Interv Radiol 4:127-137, 1993.
33. Damascelli B, Patelli G, Frigerio LF, et al. Placement of long-term central venous catheters in outpatients: Study of 134 patients over 24,596 catheter days. AJR 168:1235-1239, 1997.
34. Sweed M, Guenter P, Lucente K, et al. Long-term central venous catheters in patients with acquired immunodeficiency syndrome. Am J Infect Control 23:194-199, 1995.
35. Kenney PR, Dorfman GS, Denny DF Jr. Percutaneous inferior vena cava cannulation for long-term parenteral nutrition. Surgery 97:602-605, 1985.
36. Malmgren N, Cwikiel W, Hochbergs P, et al. Percutaneous translumbar central venous catheter in infants and small children. Pediatr Radiol 25:28-30, 1995.
37. Bennett JD, Papadouris D, Rankin RN. Percutaneous inferior vena cava approach for long-term central venous access. J Vase Interv Radiol 8:851-855, 1997.
38. Elduayen B, Martinez-Cuesta A, Vivas I, et al. Central venous catheter placement in the inferior vena cava via the direct translumbar approach. Eur Radiol 10:450-454, 2000.
39. Biswal R, Nosher JL, Siegel RL, et al. Translumbar placement of paired hemodialysis catheters (Tesio catheters) and follow-up in 10 patients. Cardiovasc Intervent Radiol 23:75-78, 2000.
40. Docktor BL, Sadler DJ, Gray RR, et al. Radiologic placement of tunneled central catheters: Rates of success and of immediate complications in a large series. AJR 173:457-460, 1999.
41. Namyslowski J, Patel NH. Central venous access: A new task for interventional radiologists. Cardiovasc Intervent Radiol 22:355-368, 1999.
42. Brown-Smith JK, Stoner MH, Barley ZA. Tunneled catheter thrombosis: Factors related to incidence. Oncol Nurs Forum 17:543-549, 1990.
43. Smith S, Dawson S, Hennessey R, et al. Maintenance of the patency of indwelling central venous catheters: Is heparin necessary? Am J Pediatr Hematol Oncol 13:141-143, 1991.
44. Ingle RJ. Rare complications of vascular access devices. Semin Oncol Nurs 11:184-193, 1995.
45. Sandstedt S, Hesselvik F, Marklund T, et al. Percutaneous, tunneled silicone elastomer central venous catheters for TPN: Low sepsis and thrombosis rate. A propective study of 325 catheters. Nutrition 5:23-26, 1989.
46. Tolar B, Gould JR. The timing and sequence of multiple device-related complications in patients with long-term indwelling Groshong catheters. Cancer 78:1308-1313, 1996.
47. Haskal ZJ, Leen VH, Thomas-Hawkins C, et al. Transvenous removal of fibrin sheaths from tunneled hemodialysis catheters. J Vase Interv Radiol 7:513-517, 1996.
48. Buckley CJ, Lee SD. Placement of vascular access devices for parenteral nutrition. Nutr Clin Prac 14:194-201, 1999.
49. Abbott Pharmacuticals Product Division, Abbott Laboratories, Abbott Park, Illinois;Website http.//www.rxabbott.com.
50. Ouriel K, Kandarpa K, Schuerr DM, et al. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety, and efficacy: The PURPOSE trial. J Vase Interv Radiol 10:1083-1091, 1999.
51. Haire WD, Atkinson JB, Stephens LC, et al. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial. Thromb Haemost 72:543-547, 1994.
52. Prandoni P, Polistena P, Bernardi E, et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 157:57-62, 1997.
53. Bolgiano EB, Foxwell MM, Browne BJ, et al. Deep vein thrombosis of the upper extremity: diagnosis and treatment. J Emerg Med 8:85-91, 1990.
54. Smith NL, Ravo B, Soroff HS, et al. Successful fibrinolytic therapy for superior vena cava thrombosis secondary to long-term TPN. JPEN 9:55-57, 1985.
55. Beers TR, Burnes J, Fleming CR. Superior vena caval obstruction in patients with gut failure receiving home parenteral nutrition. JPEN 14:474-479, 1990.
56. Belcastro S, Susa A, Pavanelli L, et al. Thrombosis of the superior vena cava due to a central catheter for TPN. JPEN 14:31-33, 1990.
57. Barclay GR, Allen K, Pennington CR. Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition. Postgrad Med J 66:398-400, 1990.
58. Muckart DJ, Neijenhuis PA, Madiba TE. Superior vena caval thrombosis complicating central venous catheterisation and TPN. S Afr J Surg 36:48-51, 1998.
59. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233-238, 1995.
60. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 112:423-428, 1990.
61. Lawson M. Partial occlusion of indwelling central venous catheters. J Intraven Nurs 14:157-159, 1991.
62. Rumsey KA, Richardson DK. Management of infection and occlusion associated with vascular access devices. Semin Oncol Nurs 11:174-183, 1995.
63. Mulloy RH, Jadavji T, Russell ML. Tunneled central venous catheter sepsis: Risk factors in a pediatric hospital. JPEN 15:460-463, 1991.
64. Raad I, Davis S, Becker M, et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 153:1791-1796, 1993.
65. Andrivet P, Bacquer A, Ngoc CV, et al. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis 18:199-206, 1994.
66. Openshaw KL, Picus D, Hicks ME, et al. Interventional radiologic placement of Hohn central venous catheters: Results and complications in 100 consecutive patients. J Vase Interv Radiol 5:111-115, 1994.
67. Salutari P, Pittiruti M, Sica S, et al. The Hohn catheter in the management of haemopoietic stem cell transplant recipients. Eur J Cancer Care (Engl) 7:201-205, 1998.
68. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver-impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 218:206-210, 1993.
69. Hemmerlein JB, Trerotola SO, Kraus MA, et al. In vitro cytotoxicity of silver-impregnated collagen cuffs designed to decrease infection in tunneled catheters. Radiology 204:363-367, 1997.
70. McKee R, Dunsmuir R, Whitby M, et al. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 6:419-425, 1985.
71. Ranson MR, Oppenheim BA, Jackson A, et al. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 15:95-102, 1990.
72. Al-Sibai MB, Harder EJ, Faskin RW, et al. The value of prophylactic antibiotics during the insertion of long-term indwelling silastic right atrial catheters in cancer patients. Cancer 60:1891-1895, 1987.
73. Bock SN, Lee RE, Fisher B, et al. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol 8:161-169, 1990.
74. Schwartz C, Henrickson KJ, Roghmann K, et al. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 8:1591-1597, 1990.
75. Krzywda EA, Andris DA, Edmiston CE Jr. Catheter infections: Diagnosis, etiology, treatment, and prevention. Nutr Clin Pract 14:178-190, 1999.
76. Benoit JL, Carandang G, Sitrin M, et al. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 21:1286-1288, 1995.
77. Buchman AL, Moukarzel A, Goodson B, et al. Catheter-related infections associated with home parenteral nutrition and predictive factors for the need for catheter removal in their treatment. JPEN 18:297-302, 1994.
78. Morello FP, Donaldson JS, Saker MC, et al. Air embolism during tunneled central catheter placement performed without general anesthesia in children: A potentially serious complication. J Vase Interv Radiol 10:781-784, 1999.
79. Aitken DR, Minton JP. The. "pinch-off sign": A warning of impending problems with permanent subclavian catheters. Am Surg 148:633-636, 1984.
80. Andris DA, Krzywda EA, Schulte W, et al. Pinch-off syndrome: A rare etiology for central venous catheter occlusion. JPEN 18:531-533, 1994.
81. Delmore JE, Horbelt DV, Jack BL, et al. Experience with the Groshong long-term central venous catheter. Gynecol Oncol 34:216-218, 1989.
82. Warner BW, Haygood MM, Davies SL, et al. A randomized, prospective trial of standard Hickman compared with Groshong central venous catheters in pediatric oncology patients. J Am Coll Surg 183:140-144, 1996.
83. Holloway RW, Orr JW. An evaluation of Groshong central venous catheters on a gynecologic oncology service. Gynecol Oncol 56:211-217, 1995.
84. Haire WD, Lieberman RP, Lund GB, et al. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: Prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 7:57-59, 1991.
85. Keung YK, Watkins K, Chen SC, et al. Comparative study of infectious complications of different types of chronic central venous access devices. Cancer 73:2832-2837, 1994.
86. Biagi E, Arrigo C, Dell'Orto MG, et al. Mechanical and infective central venous catheter-related complications: A prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies. Support Care Cancer 5:228-233, 1997.
87. Davidson H, Bowersox J, Leo R. Experience with Groshong versus Hickman central venous catheters[Abstract]. Proc Am Soc Clin Oncol 7:289, 1988.
88. Pasquale MD, Campbell JM, Magnant CM. Groshong versus Hickman catheters. Surg Gynecol Obstet 174:408-410, 1992.
89. Ryder M. The future of vascular access: will the benefits be worth the risk? Nutr Clin Pract 14:165-169, 1999.
90. Mayo DJ, Home MK 3, Summers BL, et al. The effects of heparin flush on patency of the Groshong catheter: A pilot study. Oncol Nurs Forum 23:1401-1405, 1996.
91. Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706-712, 1982.
92. Simpson KR, Hovsepian DM, Picus D. Interventional radiologic placement of chest wall ports: Results and complications in 161 consecutive placements. J Vase Interv Radiol 8:189-195, 1997.
93. Beheshti MV, Protzer WR, Tomlinson TL, et al. Long-term results of radiologic placement of a central vein access device. AJR 170:731-734, 1998.
94. Gyves J, Ensminger W, Niederhuber J, et al. Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med 73:841-845, 1982.
95. Brothers TE, Von Moll LK, Niederhuber JE, et al. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 166:295-301, 1988.
96. Biffi R, Corrado F, deBraud F, et al. Long-term totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device. Eur J Cancer 33:1190-1194, 1997.
97. McKee J. Future dimensions in vascular access-peripheral implantable ports. J Intraven Nurs 14:387-393, 1991.
98. Sotir MJ, Lewis C, Bisher EW, et al. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 20:187-191, 1999.
99. Salem RR, Ward BA, Ravikumar TS. A new peripherally implanted subcutaneous permanent central venous access device for patients requiring chemotherapy. J Clin Oncol 11:2181-2185, 1993.
100. Winters V, Peters B, Coila S, et al. A trial with a new peripheral implanted vascular access device. Oncol Nurs Forum 17:891-896, 1990.
101. Morris P, Buller R, Kendall S, et al. A peripherally implanted permanent central venous access device. Obstet Gynecol 78:1138-1142, 1991.
102. Nelson BE, Mayer AR, Tseng PC, et al. Experience with the intravenous totally implanted port in patients with gynecologic malignancies. Gynecol Oncol 53:98-102, 1994.
103. Kupensky DT. Use of hydrochloric acid to restore patency in an occluded implantable port: A case report. J Intraven Nurs 18:198-201, 1995.
104. Whigham CJ, Greenbaum MC, Fisher RG, et al. Incidence and management of catheter occlusion in implantable arm ports: Results in 391 patients. J Vase Interv Radiol 10:767-774, 1999.
105. Monreal M, Alastrue A, Rull M, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices-prophylaxis .with a low molecular weight heparin (Fragmin). Thromb Haemost 75:251-253, 1996.
106. Nostdahl T, Waagsbo NA. Costoclavicular pinching: A complication of long-term central venous catheters;a report of three cases. Acta Anaesthesiol Scand 42:872-875, 1998.
107. Severien C, Nelson JD. Frequency of infections associated with implanted systems vs cuffed, tunneled Silastic venous catheters in patients with acute leukemia. Am J Dis Child 145:1433-1438, 1991.
108. Shaw JH, Douglas R, Wilson T. Clinical performance of Hickman and Portacath atrial catheters. Aust NZ J Surg 58:657-659, 1988.
109. Mirro J Jr, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 7:214-222, 1989.
110. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168-1174, 1993.
111. Hayward SR, Ledgerwood AM, Lucas CE. The fate of 100 prolonged venous access devices. Am Surg 56:515-519, 1990.
112. La Quaglia MP, Lucas A, Thaler HT, et al. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 27:840-842, 1992.
113. Ross MN, Haase GM, Poole MA, et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 167:141-144, 1988.
114. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13:130-136, 1991.
115. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10:1943-1948, 1992.